In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis

M. Walsh, E. W. Kappus, Thomas C Quinn

Research output: Contribution to journalArticle

Abstract

The antimicrobial activity of CP-62,993 against four Chlamydia trachomatis isolates was compared with those of erythromycin, clindamycin, and tetracycline. The MIC of CP-62,993 was 0.26 to 1.02 μg/ml for 100% inclusion inhibition and 0.031 to 0.063 μg/ml for 50% inclusion inhibition. With pharmacokinetic and antimicrobial studies demonstrating prolonged half-life and in vitro effectiveness, CP-62,993 may make possible a single, short-course treatment regimen for C. trachomatis infection.

Original languageEnglish (US)
Pages (from-to)811-812
Number of pages2
JournalAntimicrobial Agents and Chemotherapy
Volume31
Issue number5
StatePublished - 1987

Fingerprint

Clindamycin
Chlamydia trachomatis
Erythromycin
Tetracycline
Chlamydia Infections
Half-Life
Pharmacokinetics
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. / Walsh, M.; Kappus, E. W.; Quinn, Thomas C.

In: Antimicrobial Agents and Chemotherapy, Vol. 31, No. 5, 1987, p. 811-812.

Research output: Contribution to journalArticle

@article{0d3918de7caa4a729c85229d60b6beaa,
title = "In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis",
abstract = "The antimicrobial activity of CP-62,993 against four Chlamydia trachomatis isolates was compared with those of erythromycin, clindamycin, and tetracycline. The MIC of CP-62,993 was 0.26 to 1.02 μg/ml for 100{\%} inclusion inhibition and 0.031 to 0.063 μg/ml for 50{\%} inclusion inhibition. With pharmacokinetic and antimicrobial studies demonstrating prolonged half-life and in vitro effectiveness, CP-62,993 may make possible a single, short-course treatment regimen for C. trachomatis infection.",
author = "M. Walsh and Kappus, {E. W.} and Quinn, {Thomas C}",
year = "1987",
language = "English (US)",
volume = "31",
pages = "811--812",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis

AU - Walsh, M.

AU - Kappus, E. W.

AU - Quinn, Thomas C

PY - 1987

Y1 - 1987

N2 - The antimicrobial activity of CP-62,993 against four Chlamydia trachomatis isolates was compared with those of erythromycin, clindamycin, and tetracycline. The MIC of CP-62,993 was 0.26 to 1.02 μg/ml for 100% inclusion inhibition and 0.031 to 0.063 μg/ml for 50% inclusion inhibition. With pharmacokinetic and antimicrobial studies demonstrating prolonged half-life and in vitro effectiveness, CP-62,993 may make possible a single, short-course treatment regimen for C. trachomatis infection.

AB - The antimicrobial activity of CP-62,993 against four Chlamydia trachomatis isolates was compared with those of erythromycin, clindamycin, and tetracycline. The MIC of CP-62,993 was 0.26 to 1.02 μg/ml for 100% inclusion inhibition and 0.031 to 0.063 μg/ml for 50% inclusion inhibition. With pharmacokinetic and antimicrobial studies demonstrating prolonged half-life and in vitro effectiveness, CP-62,993 may make possible a single, short-course treatment regimen for C. trachomatis infection.

UR - http://www.scopus.com/inward/record.url?scp=0023254967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023254967&partnerID=8YFLogxK

M3 - Article

C2 - 3038010

AN - SCOPUS:0023254967

VL - 31

SP - 811

EP - 812

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -